NASDAQ:OM Outset Medical (OM) Stock Price, News & Analysis $3.83 -0.01 (-0.26%) (As of 07/5/2024 08:53 PM ET) Add Compare Share Share Today's Range$3.70▼$3.9150-Day Range$2.53▼$4.6152-Week Range$1.92▼$20.96Volume643,700 shsAverage Volume1.20 million shsMarket Capitalization$198.09 millionP/E RatioN/ADividend YieldN/APrice Target$5.42 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get Outset Medical alerts: Email Address Outset Medical MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside41.4% Upside$5.42 Price TargetShort InterestBearish16.84% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingSelling Shares$217,924 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($2.23) to ($1.73) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.17 out of 5 starsMedical Sector720th out of 879 stocksElectromedical Equipment Industry15th out of 19 stocks 3.3 Analyst's Opinion Consensus RatingOutset Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 4 buy ratings, 1 hold rating, and 1 sell rating.Amount of Analyst CoverageOutset Medical has only been the subject of 1 research reports in the past 90 days.Read more about Outset Medical's stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted16.84% of the outstanding shares of Outset Medical have been sold short.Short Interest Ratio / Days to CoverOutset Medical has a short interest ratio ("days to cover") of 7.Change versus previous month Previous Next 0.0 Dividend Strength Dividend YieldOutset Medical does not currently pay a dividend.Dividend GrowthOutset Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for OM. Previous Next 2.8 News and Social Media Coverage News SentimentOutset Medical has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.75 average news sentiment score of Medical companies.Search Interest4 people have searched for OM on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Outset Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of -75% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Outset Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $217,924.00 in company stock.Percentage Held by InsidersOnly 3.50% of the stock of Outset Medical is held by insiders.Read more about Outset Medical's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Outset Medical are expected to grow in the coming year, from ($2.23) to ($1.73) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Outset Medical is -1.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Outset Medical is -1.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioOutset Medical has a P/B Ratio of 1.56. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Outset Medical's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Stansberry ResearchBUY ALERT: Tiny tech play partners with US governmentThe Federal Reserve is rolling out a powerful new financial technology across the entire U.S. banking system. It's forecasted to grow 24,290% in the near future... Meaning, your bank is nearly certain to adopt it (if it hasn't already).Get the full story here while you can. About Outset Medical Stock (NASDAQ:OM)Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.Read More OM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OM Stock News HeadlinesJuly 1, 2024 | investorplace.com3 MedTech Stocks to Buy for Healthy GainsMay 12, 2024 | finance.yahoo.comAnalysts Are Updating Their Outset Medical, Inc. (NASDAQ:OM) Estimates After Its First-Quarter ResultsJuly 8, 2024 | Stansberry Research (Ad)BUY ALERT: Tiny tech play partners with US governmentThe Federal Reserve is rolling out a powerful new financial technology across the entire U.S. banking system. It's forecasted to grow 24,290% in the near future... Meaning, your bank is nearly certain to adopt it (if it hasn't already).May 10, 2024 | finance.yahoo.comOutset Medical Inc (OM) Q1 2024 Earnings: Misses Revenue Estimates and Widens LossesMay 9, 2024 | markets.businessinsider.comRBC Capital Keeps Their Hold Rating on Outset Medical (OM)May 9, 2024 | finance.yahoo.comOutset Medical, Inc. (NASDAQ:OM) Q1 2024 Earnings Call TranscriptMay 9, 2024 | finance.yahoo.comOutset Medical Inc (OM) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges ...May 9, 2024 | finance.yahoo.comOutset Medical First Quarter 2024 Earnings: US$0.79 loss per share (vs US$0.90 loss in 1Q 2023)July 8, 2024 | Stansberry Research (Ad)BUY ALERT: Tiny tech play partners with US governmentThe Federal Reserve is rolling out a powerful new financial technology across the entire U.S. banking system. It's forecasted to grow 24,290% in the near future... Meaning, your bank is nearly certain to adopt it (if it hasn't already).May 8, 2024 | finance.yahoo.comOutset Medical Reports First Quarter 2024 Financial ResultsMay 8, 2024 | msn.comOutset Medical Non-GAAP EPS of -$0.57 misses by $0.02, revenue of $28.2M misses by $2.15MMay 8, 2024 | msn.comOM Stock Earnings: Outset Medical Misses EPS, Misses Revenue for Q1 2024May 6, 2024 | marketwatch.comOutset Medical Shares Rise 56% After FDA Grants Clearance for TabloCartMay 6, 2024 | msn.comWhy Outset Medical Shares Are Up TodayMay 6, 2024 | msn.comOutset Medical stock rallies 40% on FDA clearance of dialysis deviceMay 6, 2024 | markets.businessinsider.comWhy Outset Medical Is Rising In Pre-market?May 6, 2024 | businesswire.comOutset Medical's TabloCart with Prefiltration Receives FDA 510(k) ClearanceMay 1, 2024 | businesswire.comOutset Medical to Present at Upcoming Investor ConferencesSee More Headlines Receive OM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Outset Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/08/2024Today7/07/2024Next Earnings (Estimated)8/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryN/A Current SymbolNASDAQ:OM CUSIPN/A CIK1484612 Weboutsetmedical.com Phone669-231-8200FaxN/AEmployees480Year FoundedN/APrice Target and Rating Average Stock Price Target$5.42 High Stock Price Target$6.00 Low Stock Price Target$3.00 Potential Upside/Downside+41.4%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)($3.38) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-172,800,000.00 Net Margins-134.93% Pretax Margin-134.54% Return on Equity-120.67% Return on Assets-51.09% Debt Debt-to-Equity Ratio2.11 Current Ratio6.42 Quick Ratio5.32 Sales & Book Value Annual Sales$130.38 million Price / Sales1.52 Cash FlowN/A Price / Cash FlowN/A Book Value$2.45 per share Price / Book1.56Miscellaneous Outstanding Shares51,720,000Free Float49,912,000Market Cap$198.09 million OptionableNot Optionable Beta2.00 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMs. Leslie L. Trigg (Age 53)President, CEO & Chairman Comp: $1.22MMr. Nabeel Ahmed (Age 48)Chief Financial Officer Comp: $654.74kMr. John L. Brottem (Age 49)General Counsel & Secretary Comp: $594.15kMr. Marc Nash (Age 35)Senior Vice President of Operations and R&D Mr. Jean-Olivier Racine (Age 42)Chief Technology Officer Comp: $540.93kMr. James S. MazzolaHead of Investor RelationsNicole ShannonDirector of Marketing CommunicationsDr. Michael Aragon M.D.Chief Medical OfficerMr. Mark Gordon M.S. (Age 67)Chief Regulatory & Quality Officer More ExecutivesKey CompetitorsAxoGenNASDAQ:AXGNZynexNASDAQ:ZYXISemler ScientificNASDAQ:SMLREdap TmsNASDAQ:EDAPElectromedNYSE:ELMDView All CompetitorsInsiders & InstitutionsD Keith GrossmanSold 38,117 sharesTotal: $144,082.26 ($3.78/share)Leslie TriggSold 5,237 sharesTotal: $18,486.61 ($3.53/share)Jacobs Levy Equity Management Inc.Bought 91,256 shares on 5/16/2024Ownership: 0.770%Nabeel AhmedSold 3,918 sharesTotal: $13,830.54 ($3.53/share)John L BrottemSold 2,972 sharesTotal: $10,491.16 ($3.53/share)View All Insider TransactionsView All Institutional Transactions OM Stock Analysis - Frequently Asked Questions How have OM shares performed this year? Outset Medical's stock was trading at $5.41 at the start of the year. Since then, OM stock has decreased by 29.2% and is now trading at $3.83. View the best growth stocks for 2024 here. How were Outset Medical's earnings last quarter? Outset Medical, Inc. (NASDAQ:OM) posted its quarterly earnings results on Wednesday, May, 8th. The company reported ($0.73) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.60) by $0.13. The business earned $28.17 million during the quarter, compared to analysts' expectations of $30.55 million. Outset Medical had a negative net margin of 134.93% and a negative trailing twelve-month return on equity of 120.67%. When did Outset Medical IPO? Outset Medical (OM) raised $175 million in an IPO on Tuesday, September 15th 2020. The company issued 7,600,000 shares at $22.00-$24.00 per share. BofA Securities, Morgan Stanley and Goldman Sachs served as the underwriters for the IPO and SVB Leerink and Stifel were co-managers. How do I buy shares of Outset Medical? Shares of OM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:OM) was last updated on 7/8/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredOperation Replace Biden is a GoLast night’s debate proved me right: Joe Biden will be replaced. I’ve been making this warning for months… ...The Freeport Society | SponsoredObama wins Presidential debate When I said Obama would seek a third term… They called me a conspiracy theorist, they said it couldn’t happ...Porter & Company | Sponsored270x more lucrative than NVIDIA???If you've missed out on NVIDIA's recent 1,600% run... Don't worry. Because there's one AI stock that cou...Behind the Markets | SponsoredObama’s DNC coupAs we approach the Democratic National Convention in August... many sense a Biden swap-out is looming. In f...Stansberry Research | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredExposed: 3 CENT Crypto to Explode June 24th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Outset Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Outset Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.